
DOI . ORG {
}
Title[redir]:
Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilsonâs disease | Current Medical Science
Description:
The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilsonâs disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
Matching Content Categories {đ}
- Science
- Health & Fitness
- Insurance
Content Management System {đ}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of doi.org audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {đ¸}
We can't see how the site brings in money.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {đ}
article, disease, wilsons, treatment, patients, dmps, google, scholar, penicillamine, pubmed, efficacy, cross, combination, intravenous, adverse, effects, access, cas, privacy, cookies, content, journal, chelation, repeatedly, pca, oral, zinc, therapy, information, publish, search, huazhong, medical, clinical, safety, sodium, drug, neurol, sci, data, log, research, university, science, technology, zhu, ling, chen, copper, open,
Topics {âď¸}
3-dimercapto-1-propane sulfonate month download article/chapter short-term intravenous dmps zinc versus d-penicillamine authors contributed equally full article pdf privacy choices/manage cookies maitain lifelong therapy initial penicillamine therapy related subjects tongji medical college xu-fang li european economic area poor curative effect susceptibility-weighted imaging expert opin pharmacother rare genetic disorder decompensated liver cirrhosis clin pharm ther article xu conditions privacy policy urine copper excretion urine copper tended combined chelation regimen hui-yun zhu accepting optional cookies administrated intravenous dmps adverse effects recovered liver function alleviated neurologic symptoms intravenous dmps alternately combined sodium dimercaptopropanesulfonate alternative orphan medicines key words wilson journal finder publish article journal oral pca alternately check access instant access clinical efficacy article log symptomatic wilson disease author correspondence oral pca treatment article cite line therapy anticopper efficacy chelation treatment repeatedly d-penicillamine medical center
Schema {đşď¸}
WebPage:
mainEntity:
headline:Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilsonâs disease
description:The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilsonâs disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
datePublished:2013-10-20T00:00:00Z
dateModified:2013-10-20T00:00:00Z
pageStart:743
pageEnd:747
sameAs:https://doi.org/10.1007/s11596-013-1190-z
keywords:
Wilsonâs disease
sodium 2, 3-dimercapto-1-propane sulfonate
penicillamine
efficacy
adverse effects
Medicine/Public Health
general
image:
isPartOf:
name:Journal of Huazhong University of Science and Technology [Medical Sciences]
issn:
1993-1352
1672-0733
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:San-qing Xu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Xu-fang Li
affiliation:
name:Guangzhou Women and Childrenâs Medical Center
address:
name:Department of Pediatrics, Guangzhou Women and Childrenâs Medical Center, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Hui-yun Zhu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Yan Liu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Fang
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Ling Chen
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilsonâs disease
description:The aim of this study was to assess the clinical efficacy and safety of chelation treatment with penicillamine (PCA) in cross combination with sodium 2, 3-dimercapto-1-propane sulfonate (DMPS) repeatedly in patients with Wilsonâs disease (WD). Thirty-five patients with WD were enrolled. They were administrated intravenous DMPS in cross combination with oral PCA alternately which was practiced repeatedly, all with Zinc in the meantime. During the treatment, clinical observations and 24-h urine copper excretion as well as adverse effects of medicines were recorded and analyzed. Although the incidence of adverse effects was not significantly different after either intravenous DMPS or oral PCA treatment, levels of 24-h urine copper tended to be higher after short-term intravenous DMPS than that of oral PCA. Adverse effects in the course of intravenous DMPS were mainly neutropenia, thrombocytopenia, allergic reaction and bleeding tendency. As compared with oral PCA alone or intravenous DMPS alone, such repeated cross combination treatment could as much as possible avoid continued drug adverse effects or poor curative effect and had less chance to stop treatment in WD patients. Improved or recovered liver function in 71% of the patients, alleviated neurologic symptoms in 50% of the patients, and disappeared hematuria in 70% of the patients could be observed during the follow-up period of 6 months to 5 years after such combined chelation regimen. Chelation treatment repeatedly with oral penicillamine in cross combination with intravenous DMPS alternately could be more beneficial for WD patients to relieve symptoms, avoid continued drug adverse effects and maitain lifelong therapy.
datePublished:2013-10-20T00:00:00Z
dateModified:2013-10-20T00:00:00Z
pageStart:743
pageEnd:747
sameAs:https://doi.org/10.1007/s11596-013-1190-z
keywords:
Wilsonâs disease
sodium 2, 3-dimercapto-1-propane sulfonate
penicillamine
efficacy
adverse effects
Medicine/Public Health
general
image:
isPartOf:
name:Journal of Huazhong University of Science and Technology [Medical Sciences]
issn:
1993-1352
1672-0733
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:San-qing Xu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Xu-fang Li
affiliation:
name:Guangzhou Women and Childrenâs Medical Center
address:
name:Department of Pediatrics, Guangzhou Women and Childrenâs Medical Center, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Hui-yun Zhu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Yan Liu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Fang
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
type:Person
name:Ling Chen
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Huazhong University of Science and Technology [Medical Sciences]
issn:
1993-1352
1672-0733
volumeNumber:33
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
name:Guangzhou Women and Childrenâs Medical Center
address:
name:Department of Pediatrics, Guangzhou Women and Childrenâs Medical Center, Guangzhou, China
type:PostalAddress
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:San-qing Xu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
name:Xu-fang Li
affiliation:
name:Guangzhou Women and Childrenâs Medical Center
address:
name:Department of Pediatrics, Guangzhou Women and Childrenâs Medical Center, Guangzhou, China
type:PostalAddress
type:Organization
name:Hui-yun Zhu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
name:Yan Liu
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
name:Feng Fang
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
name:Ling Chen
affiliation:
name:Huazhong University of Science and Technology
address:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
name:Department of Pediatrics, Guangzhou Women and Childrenâs Medical Center, Guangzhou, China
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
name:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {đ}(108)
- How much does https://link.springer.com/privacystatement bring in each month?
- Income figures for https://link.springer.com/article/10.1007/s11596-013-1190-z/#main
- How much income does https://link.springer.com have?
- https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s11596-013-1190-z's revenue stream
- Find out how much https://link.springer.com/article/10.1007/s11596-013-1190-z/#eds-c-header-nav earns monthly
- What's https://link.springer.com/journals/'s gross income?
- What are the earnings of https://www.springernature.com/gp/authors?
- How much income does https://link.springernature.com/home/ have?
- Financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/#eds-c-header-popup-search
- How much income is https://order.springer.com/public/cart earning monthly?
- What's the financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/?
- What's the revenue for https://link.springer.com/article/10.1007/s11596-013-1190-z/journal/11596?
- What's the profit of https://link.springer.com/article/10.1007/s11596-013-1190-z/#citeas?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/journal/11596/aims-and-scope gross monthly?
- Earnings of https://www.editorialmanager.com/tcms/
- What's the income generated by https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-San_qing-Xu-Aff1 each month?
- How much money does https://link.springer.com/article/10.1007/s11596-013-1190-z/#Aff1 generate?
- What's the income of https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-Xu_fang-Li-Aff2?
- Earnings of https://link.springer.com/article/10.1007/s11596-013-1190-z/#Aff2
- Financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-Hui_yun-Zhu-Aff1
- What is the monthly revenue of https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-Yan-Liu-Aff1?
- What's the financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-Feng-Fang-Aff1?
- Profit of https://link.springer.com/article/10.1007/s11596-013-1190-z/#auth-Ling-Chen-Aff1
- Revenue of https://link.springer.com/article/10.1007/s11596-013-1190-z/article/10.1007/s11596-013-1190-z/metrics
- How much does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs11596-013-1190-z pull in monthly?
- What's the financial gain of https://link.springer.com/product/springer-plus?
- Learn how profitable https://www.springernature.com/gp/librarians/licensing/agc/journals is on a monthly basis
- What are the total earnings of https://link.springer.com/10.1186/s12883-020-01827-9?fromPaywallRec=true?
- How much does https://link.springer.com/10.1186/s13023-024-03271-1?fromPaywallRec=true pull in?
- How much cash flow does https://link.springer.com/10.1007/s00415-020-09746-y?fromPaywallRec=true have monthly?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/subjects/drug-therapy pull in monthly?
- Profit of https://link.springer.com/article/10.1007/s11596-013-1190-z/subjects/drug-screening
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/subjects/drugs net monthly?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/subjects/neuropharmacology rake in every month?
- Financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/subjects/toxicology
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17276780?
- How much income is https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:CAS:528:DC%2BD2sXht1OrsLc%3D earning monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Wilson%E2%80%99s%20disease&journal=Lancet&doi=10.1016%2FS0140-6736%2807%2960196-2&volume=369&issue=9559&pages=397-408&publication_year=2007&author=Ala%2CA&author=Walker%2CAP&author=Ashkan%2CK gross monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16448326
- What is the monthly revenue of https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:CAS:528:DC%2BD28XpsVarug%3D%3D?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Novel%20therapeutic%20approaches%20to%20the%20treatment%20of%20Wilson%E2%80%99s%20disease&journal=Expert%20Opin%20Pharmacother&doi=10.1517%2F14656566.7.3.317&volume=7&issue=3&pages=317-324&publication_year=2006&author=Brewer%2CGJ?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3579660 have?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:STN:280:DyaL2s3ht1KrsQ%3D%3D make?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Worsening%20of%20neurologic%20syndrome%20in%20patients%20with%20Wilson%E2%80%99s%20disease%20with%20initial%20penicillamine%20therapy&journal=Arch%20Neurol&doi=10.1001%2Farchneur.1987.00520170020016&volume=44&issue=5&pages=490-493&publication_year=1987&author=Brewer%2CGJ&author=Terry%2CCA&author=Aisen%2CAM earns monthly
- Get to know https://link.springer.com/doi/10.1007/s11910-002-0007-4's earnings
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12044251
- How much money does http://scholar.google.com/scholar_lookup?&title=Diagnosis%20and%20treatment%20of%20Wilson%E2%80%99s%20disease&journal=Curr%20Neurol%20Neurosci%20Rep&doi=10.1007%2Fs11910-002-0007-4&volume=2&issue=4&pages=317-323&publication_year=2002&author=Subramanian%2CI&author=Vanek%2CZF&author=Bronstein%2CJM make?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19731238
- What's the revenue for https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsV2js7%2FK?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Long-term%20exclusive%20zinc%20monotherapy%20in%20symptomatic%20Wilson%20disease%3A%20experience%20in%2017%20patients&journal=Hepatology&doi=10.1002%2Fhep.23182&volume=50&issue=5&pages=1442-1452&publication_year=2009&author=Linn%2CF&author=Houwen%2CR&author=Hattum%2CJ have monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=The%20treatment%20of%20Wilson%E2%80%99s%20disease%2C%20a%20rare%20genetic%20disorder%20of%20copper%20metabolism&journal=Sci%20Prog&doi=10.3184%2F003685013X13587771579987&volume=96Pt1&pages=19-32&publication_year=2013&author=Purchase%2CR
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17765927 make?
- What's the financial gain of https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:CAS:528:DC%2BD2sXhsVWjsL%2FI?
- How much does http://scholar.google.com/scholar_lookup?&title=Withdrawal%20of%20penicillamine%20from%20zinc%20sulphate-penicillamine%20maintenance%20therapy%20in%20Wilson%E2%80%99s%20disease%3A%20promising%2C%20safe%20and%20cheap&journal=J%20Neurol%20Sci&doi=10.1016%2Fj.jns.2007.08.006&volume=264&issue=1-2&pages=129-132&publication_year=2008&author=Sinha%2CS&author=Taly%2CAB net monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17286794 make?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/articles/cas-redirect/1:CAS:528:DC%2BD2sXjsVOhu7Y%3D pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Discontinuation%20of%20penicillamine%20in%20the%20absence%20of%20alternative%20orphan%20medicines%20%28trientine-zinc%29%3A%20a%20case%20of%20decompensated%20liver%20cirrhosis%20in%20Wilson%E2%80%99s%20disease&journal=J%20Clin%20Pharm%20Ther&doi=10.1111%2Fj.1365-2710.2007.00794.x&volume=32&issue=1&pages=101-107&publication_year=2007&author=Ping%2CCC&author=Hassan%2CY&author=Aziz%2CNA rake in every month?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14703896
- How much money does http://scholar.google.com/scholar_lookup?&title=Anticopper%20efficacy%20of%20captopril%20and%20sodium%20dimercaptosulphonate%20in%20patients%20with%20Wilson%E2%80%99s%20disease&journal=Funct%20Neurol&volume=18&issue=3&pages=149-153&publication_year=2003&author=Wang%2CXP&author=Yang%2CRM&author=Ren%2CMS generate?
- Learn how profitable https://citation-needed.springer.com/v2/references/10.1007/s11596-013-1190-z?format=refman&flavour=references is on a monthly basis
- What's the income generated by https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=San-qing%20Xu each month?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=San-qing%20Xu makes per month
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22San-qing%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income of https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=Xu-fang%20Li?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xu-fang%20Li's revenue stream
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xu-fang%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much does https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=Hui-yun%20Zhu make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hui-yun%20Zhu gross monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hui-yun%20Zhu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=Yan%20Liu income
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yan%20Liu bring in each month?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yan%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Financial intake of https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=Feng%20Fang
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feng%20Fang rake in every month?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feng%20Fang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- https://link.springer.com/article/10.1007/s11596-013-1190-z/search?sortBy=newestFirst&dc.creator=Ling%20Chen's total income per month
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ling%20Chen make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ling%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- What's the monthly money flow for https://link.springer.com/article/10.1007/s11596-013-1190-z/mailto:[email protected]?
- How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Clinical%20efficacy%20and%20safety%20of%20chelation%20treatment%20with%20typical%20penicillamine%20in%20cross%20combination%20with%20DMPS%20repeatedly%20for%20Wilson%E2%80%99s%20disease&author=San-qing%20Xu%20%E5%BE%90%E4%B8%89%E6%B8%85%20et%20al&contentID=10.1007%2Fs11596-013-1190-z©right=Huazhong%20University%20of%20Science%20and%20Technology%20and%20Springer-Verlag%20Berlin%20Heidelberg&publication=1672-0733&publicationDate=2013-10-20&publisherName=SpringerNature&orderBeanReset=true generate?
- What's the monthly money flow for https://citation-needed.springer.com/v2/references/10.1007/s11596-013-1190-z?format=refman&flavour=citation?
- How much revenue does https://link.springer.com/article/10.1007/s11596-013-1190-z/search?query=Wilson%E2%80%99s%20disease&facet-discipline="Medicine%20%26%20Public%20Health" produce monthly?
- Learn about the earnings of https://link.springer.com/article/10.1007/s11596-013-1190-z/search?query=sodium%202%2C%203-dimercapto-1-propane%20sulfonate&facet-discipline="Medicine%20%26%20Public%20Health"
- How much profit is https://link.springer.com/article/10.1007/s11596-013-1190-z/search?query=penicillamine&facet-discipline="Medicine%20%26%20Public%20Health" making per month?
- How much profit does https://link.springer.com/article/10.1007/s11596-013-1190-z/search?query=efficacy&facet-discipline="Medicine%20%26%20Public%20Health" generate?
- How much profit does https://link.springer.com/article/10.1007/s11596-013-1190-z/search?query=adverse%20effects&facet-discipline="Medicine%20%26%20Public%20Health" make?
- What's the profit of https://link.springer.com/journals/a/1?
- How much money does https://link.springer.com/books/a/1 generate?
- What is the earnings of https://link.springer.com/journals?
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's financial summary
- What's https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's gross income?
- What is the earnings of https://www.springernature.com/gp/products?
- What is the earnings of https://www.springernature.com/gp/librarians?
- Find out how much https://www.springernature.com/gp/societies earns monthly
- What's the financial outcome of https://www.springernature.com/gp/partners?
- Get to know https://www.springer.com/'s earnings
- What's https://www.nature.com/'s gross income?
- Earnings of https://www.biomedcentral.com/
- Get to know what's the income of https://www.palgrave.com/
- What's https://www.apress.com/'s gross income?
- How much does https://link.springer.com/brands/discover net monthly?
- What's the total monthly financial gain of https://www.springernature.com/gp/legal/ccpa?
- What's the revenue for https://www.springernature.com/gp/info/accessibility?
- Explore the financials of https://link.springer.com/termsandconditions
- What's the monthly income of https://support.springernature.com/en/support/home?
- Find out how much https://link.springer.com/legal-notice earns monthly
- https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's total income per month
- How much profit does https://www.springernature.com/ make?
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Prism.js
Emails and Hosting {âď¸}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {đŚ}
- Crossref